CAS: 1258417-54-7
ACT-389949
CAS:1258417-54-7
ACT-389949: Potent, selective FPR2/ALX agonist; EC50 3 nM; potential inflammatory disorder treatment.
Formula:
C20H18F2N6O3
Purity:
99.40%
Color and Shape:
Solid
Molecular weight:
428.39
Ref: TM-T10242
| 1mg | 97.00 € | ||
| 5mg | 144.00 € | ||
| 10mg | 215.00 € | ||
| 25mg | 378.00 € | ||
| 50mg | 562.00 € | ||
| 100mg | 843.00 € |
Estimated delivery in United States, on Tuesday 4 Mar 2025
N-(2-((4-(1,1-Difluoroethyl)oxazol-2-yl)methyl)-2H-1,2,3-triazol-4-yl)-2-methyl-5-(m-tolyl)oxazole-4-carboxamide
CAS:1258417-54-7
Formula:
C20H18F2N6O3
Purity:
98%
Color and Shape:
Solid
Molecular weight:
428.3921
Ref: IN-DA01N18B
| 5mg | 140.00 € | ||
| 10mg | 162.00 € | ||
| 25mg | 298.00 € | ||
| 50mg | 608.00 € |
Estimated delivery in United States, on Tuesday 4 Mar 2025
ACT-389949
CAS:1258417-54-7
ACT-389949 is a novel small molecule that has been shown to be a potent inhibitor …
Formula:
C20H18F2N6O3
Purity:
Min. 95%
Molecular weight:
428.4 g/mol
Ref: 3D-IAC41754
| 25mg | 1,073.00 € | ||
| 50mg | 1,493.00 € | ||
| 100mg | 2,388.00 € |
Estimated delivery in United States, on Tuesday 15 Apr 2025
